We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.4B
AUM Growth
+$1.28B
Cap. Flow
+$190M
Cap. Flow %
1.67%
Top 10 Hldgs %
17.01%
Holding
369
New
14
Increased
138
Reduced
152
Closed
7

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$30.3M
2
AAPL icon
Apple
AAPL
+$23.4M
3
MCO icon
Moody's
MCO
+$22.1M
4
MANH icon
Manhattan Associates
MANH
+$20.9M
5
CPK icon
Chesapeake Utilities
CPK
+$18.7M

Sector Composition

Rank Sector Weight
1 Technology 17.69%
2 Healthcare 17.31%
3 Financials 16.14%
4 Industrials 14.89%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGX icon
201
Quest Diagnostics
DGX
$25.9B
$9.95M 0.09%
63,575
+15,675
+33% +$2.25M
AVB icon
202
AvalonBay Communities
AVB
$26.8B
$9.32M 0.08%
57,715
+9,135
+19% +$1.55M
CAC icon
203
Camden National
CAC
$977M
$9.03M 0.08%
216,605
-1,436
-0.7% -$61.1K
VWO icon
204
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$8.94M 0.08%
229,358
-20,361
-8% -$776K
AME icon
205
Ametek
AME
$55B
$8.87M 0.08%
63,510
-8,155
-11% -$1.08M
ULTA icon
206
Ulta Beauty
ULTA
$22.2B
$8.84M 0.08%
18,840
-210
-1% -$90.6K
RY icon
207
Royal Bank of Canada
RY
$292B
$8.4M 0.07%
89,390
+22,300
+33% +$2.11M
TXN icon
208
Texas Instruments
TXN
$255B
$8.36M 0.07%
50,588
+16,425
+48% +$2.74M
GABC icon
209
German American Bancorp
GABC
$1.92B
$8.33M 0.07%
223,448
-1,528
-0.7% -$58.2K
TJX icon
210
TJX Companies
TJX
$176B
$8.3M 0.07%
104,281
+2,532
+2% +$187K
VOO icon
211
Vanguard S&P 500 ETF
VOO
$972B
$8.22M 0.07%
23,409
WST icon
212
West Pharmaceutical
WST
$23.9B
$8.12M 0.07%
+34,515
New +$8.18M
ANSS
213
DELISTED
Ansys
ANSS
$7.74M 0.07%
32,054
+8,135
+34% +$1.89M
VSGX icon
214
Vanguard ESG International Stock ETF
VSGX
$6.53B
$7.67M 0.07%
155,960
-11,475
-7% -$545K
MTB icon
215
M&T Bank
MTB
$35.8B
$7.56M 0.07%
52,122
+85
+0.2% +$14K
INTC icon
216
Intel
INTC
$460B
$7.49M 0.07%
283,390
+42,990
+18% +$1.19M
EQNR icon
217
Equinor
EQNR
$96.8B
$7.2M 0.06%
201,000
ANET icon
218
Arista Networks
ANET
$215B
$7.15M 0.06%
235,680
-2,160
-0.9% -$66.5K
ROK icon
219
Rockwell Automation
ROK
$52.4B
$7.15M 0.06%
27,745
-195
-0.7% -$49K
ARE icon
220
Alexandria Real Estate Equities
ARE
$9.15B
$6.65M 0.06%
45,685
+1,505
+3% +$218K
VRSK icon
221
Verisk Analytics
VRSK
$26.1B
$6.44M 0.06%
36,521
+726
+2% +$128K
ABT icon
222
Abbott
ABT
$183B
$5.89M 0.05%
53,624
-344
-0.6% -$35.6K
LIN icon
223
Linde
LIN
$235B
$5.76M 0.05%
17,669
+341
+2% +$107K
BRO icon
224
Brown & Brown
BRO
$23.7B
$5.67M 0.05%
99,598
+12,575
+14% +$735K
CTSH icon
225
Cognizant
CTSH
$24.3B
$5.66M 0.05%
98,950
+25,340
+34% +$1.49M

Similar funds

Boston Trust Walden's Q4 2022 Portfolio in Review

As of Q4 2022, Boston Trust Walden held 369 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Trust Walden's Q4 2022 filing shows 14 new, 138 increased, 152 reduced and 7 closed positions. Its largest new stake was BJs Wholesale Club: 726,376 shares worth $48.1M. The largest sale was Medpace, an estimated $30.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q4 2022 buy was BJs Wholesale Club: 726,376 shares worth $48.1M.
  • Boston Trust Walden added most to Littelfuse in Q4 2022, an estimated $25.5M increase.
  • Boston Trust Walden's biggest Q4 2022 reduction was Medpace, cutting an estimated $30.3M.
  • Boston Trust Walden fully exited Chesapeake Utilities in Q4 2022, selling an estimated $18.7M.
  • Boston Trust Walden's ten largest holdings make up 17% of its $11.4B portfolio in Q4 2022.
  • Boston Trust Walden opened 14 new positions and closed 7 in Q4 2022.
  • Boston Trust Walden's portfolio value rose 13% quarter-over-quarter to $11.4B.

Based on Boston Trust Walden's 13F filing for Q4 2022, filed 20 Jan 2023.